TipRanks
Go Ultimate55% OFF

James Patrick Kelly Insider Profile

11 Followers

James Patrick Kelly, EVP, CFO & Treas at Novavax, holds 130.60K shares in Novavax (Ticker: NVAX), holds ― shares in Supernus Pharmaceuticals (Ticker: SUPN), holds 186.87K shares in Vanda (Ticker: VNDA).

James Patrick Kelly's Trading History

NVAX
Novavax
Mar 09, 2026EVP, CFO & TreasUninformative Buy63.06K$1.32M
VNDA
Vanda
Mar 04, 2020EVP & CFOInformative Sell195.32K$708.23K
SUPN
Supernus Pharmaceuticals
―Executive Vice-President & CFO――

You May Also Like

James Patrick Kelly insider profile FAQ

What is the percentage of profitable transactions made by James Patrick Kelly?
The percentage of profitable transactions made by James Patrick Kelly is 60%.
What is the average return per transaction made by James Patrick Kelly?
The average return per transaction made by James Patrick Kelly is 8.00%.
What stocks does James Patrick Kelly hold?
James Patrick Kelly holds: NVAX, SUPN, VNDA stocks.
What was James Patrick Kelly’s latest transaction?
James Patrick Kelly’s latest transaction was an Uninformative Buy of $63.06K.
What was James Patrick Kelly's most profitable transaction?
James Patrick Kelly’s most profitable transaction was an Informative Sell of VNDA stock on March 4, 2019. The return on the trade was 42.50%.
What is James Patrick Kelly's role in Novavax?
James Patrick Kelly's role in Novavax is EVP, CFO & Treas.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.